EN DE

Intermedical Care and Lab Hospital Public Company Limited (IMH) Fair Value & Analysis

Healthcare · TH · Market cap 706M THB (≈ $21.3M)

IC Intermedical Care and Lab Hospital Public Company Limited IMH · BK
Price3.72 THB
Fair Value3.91 THB
Upside+5.1%
Quality30/100
Watch Intermedical Care and Lab Hospital Public Company Limited for free, get notified when fair value or trend changes. Watch for free

Strengths

Moderate debt · generates free cash flow

Risks

!Mixed Growth (revenue 5y +25.9 %/yr)
!Loss-making · -21.7% net margin
!Mixed vs. peers (4/10)
!Narrow moat 27/100
Mixed Growth (revenue 5y +25.9 %/yr)
Loss-making · -21.7% net margin
Moderate debt · generates free cash flow
Mixed vs. peers (4/10)
Narrow moat 27/100
Evidence: Low Range 1.34 THB – 3.91 THB Share as image

Fair value as of: Aug 13, 2026

From 7 valuation models · updated 17 days ago

Fair value updated Aug 13, 2026, revised from 4.55 THB to 3.91 THB (−14.1%) since Jul 16, 2026. Share price +24.0% over the past month.

Below-average quality, currently priced close to our fair value.

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Track Intermedical Care and Lab Hospital Public Company Limited and get told automatically when its fair value or trend turns, plus fair value for all 35,000+ stocks. 14 days of Pro free, no card. Track it free

What matters now

  • The model range is unusually wide (1.34 THB to 3.91 THB). The outcome hinges heavily on assumptions, so read the point estimate with caution.
  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
  • Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

21.29 THB 2.84 THB Fair Value 3.91 THB Mar 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range 2.84 THB – 21.29 THB · fair‑value band 1.34 THB – 3.91 THB · the 3.72 THB price screens below the 3.91 THB fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Intermedical Care and Lab Hospital Public Company Limited (IMH) currently trades at 3.72 THB, while our model-based Fair Value estimate is 3.91 THB, implying the stock looks roughly 5.1% fairly valued today. The Quality Score stands at 30/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.

Over the trailing twelve months, Intermedical Care and Lab Hospital Public Company Limited generated revenue of 764M THB at a net margin of -24.7%. Revenue declined 1.3% year over year. It earns a return on equity of -28.3%. Net debt stands at 1.1B THB. Fundamentals as of Aug 13, 2026

Our scenario range runs from 1.34 THB (bear case) to 3.91 THB (bull case); at 3.72 THB, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 17% below its 52-week high and 38% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -7% fair-value upside, at 5%, IMH screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF 1.80 THB 4.69 THB 8.63 THB 74
FCF DCF 1.92 THB 4.73 THB 10.40 THB 73
5Y Revenue Exit 1.40 THB 4.05 THB 7.75 THB 68
All 7 models by family
DCF Models
FCF DCF 1.92 THB 4.73 THB 10.40 THB 73
5Y Revenue Exit 1.40 THB 4.05 THB 7.75 THB 68
10Y Revenue Exit 1.45 THB 3.96 THB 8.03 THB 62
Multiples
EV/Revenue 1.13 THB 2.43 THB 3.74 THB 51
Asset-Based
NCAV (Graham) 1.15 THB 1.53 THB 2.29 THB 54
Growth DCF
Growth DCF 1.80 THB 4.69 THB 8.63 THB 74
Rev-Margin DCF 1.40 THB 3.96 THB 7.49 THB 68

Widest divergence: DCF Models (4.05 THB) versus Asset-Based (1.53 THB). Highest evidence: Growth DCF (74).

Notify me when IMH reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

P/S ratio 0.90 TTM
EPS (TTM) -0.7500 THB
Net margin -25.0% FY2025
Return on equity -28.3% TTM
Return on assets (EBIT) 12.3% avg 5y
Operating margin -27.3% TTM
More key figures
Growth
Revenue (TTM) 764M THB TTM
Revenue growth (YoY) +1.6% 3y avg +5.7%
EPS growth (YoY) +279%
Balance sheet & cash flow
Free cash flow 79.3M THB FY2025
Net debt 1.1B THB FY2025 · ≈ 13.3 yrs of FCF

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 30/100

Of which business quality 31 · Market factors (momentum, volatility) 59

Profitability 5
Margins and returns on capital today
Quality Growth 11
Are margins and returns improving?
Cashflow 59
Earnings quality: real cash, not paper profit
Fin. Strength 19
Balance sheet, leverage, solvency risk
Investment 65
Disciplined investing over empire-building
Low Volatility 88
Calm price path (market factor)
Momentum 50
Price trend over the last 3–12 months (market factor)
52W Momentum 42
Distance to the 52-week high (market factor)
Net Issuance 40
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.

About the company

Intermedical Care and Lab Hospital Public Company Limited operates a network of private hospitals specializing in occupational medicine in Thailand. It operates through Hospital and Occupational Medicine Hospital segments.

Full company description

Intermedical Care and Lab Hospital Public Company Limited operates a network of private hospitals specializing in occupational medicine in Thailand. It operates through Hospital and Occupational Medicine Hospital segments. The company offers specialized occupational medicine hospital, medical services, and medical diagnosis, as well as health check-up and consultation services. Its clinics and medical centers includes ear, nose, and throat; orthopedic; general internal medicine; nephrology; medical oncology; hematology; cardiology; general surgery; urology; neurosurgery; colorectal surgery; cardiothoracic surgery; vascular surgery; obstetrics and gynecology; general dentistry; pediatrics; neurology; psychiatry; ophthalmology; and forensic medicine departments. The company serves government and private sector customers. Intermedical Care and Lab Hospital Public Company Limited was incorporated in 1996 and is headquartered in Bangkok, Thailand.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Intermedical Care and Lab Hospital Public Company Limited reported revenue of 755M THB in FY2025 versus 943M THB in FY2021, a compound −5.4%/yr. Reported net income was −189M THB in FY2025.

Growth Quality 61/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
755M THB
Latest YoY
−2.1%
Avg. revenue growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+5.7%
Avg. revenue growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+25.9%
Avg. revenue growth/yr (10Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+13.5%
Value creation/yr We only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Revenue −5.4%/yr
FY21 943M THB
FY22 640M THB
FY23 670M THB
FY24 771M THB
FY25 755M THB
Net income
FY21 423M THB
FY22 173M THB
FY23 21.5M THB
FY24 −74.5M THB
FY25 −189M THB

Watch IMH: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Intermedical Care and Lab Hospital Public Company Limited Fair Value". https://www.fairvalue-calculator.com/stock/IMH

Peer Group

Medical Care Facilities · 267 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 30 · Bottom 25%
Fair Value upside +5% · Above median
Return on assets -3% · Bottom 25%
Net margin (TTM) -22% · Bottom 25%
Operating margin (TTM) 22% · Top 25%
Revenue growth 2% · Below median
Debt / equity 0.89× · Higher than 75% of peers

Valuation Multiples vs Medical Care Facilities median · lower = cheaper

P/S (TTM) 0.03× · Cheaper than 75% of peers
P/FCF 0.3× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE40 · sector 26
FUTURE8 · sector 25
PAST0 · sector 30
HEALTH56 · sector 90
DIVIDEND0 · sector 40

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
HCA Healthcare, Inc HCA $427.16 $547.67 +28%
Fresenius SE FRE €46.20 €32.15 -30%
Dr. Sulaiman Al Habib Medical Services Group 4013 241.00 SAR 112.37 SAR -53%
IHH Healthcare Berhad, an investment holding company, Q0F 2.67 SGD 1.44 SGD -46%
Tenet Healthcare Corporation THC $266.80 $330.25 +24%
DaVita Inc DVA $180.05 $186.49 +4%
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹8,818 ₹2,955 -66%
Fresenius Medical Care AG FME €39.92 €71.28 +79%
Aier Eye Hospital Group 300015 ¥8.25 ¥7.67 -7%
Max Healthcare Institute Limited MAXHEALTH ₹1,005 ₹284.87 -72%

Compare Intermedical Care and Lab Hospital Public Company Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Discover undervalued stocks

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screener Filter by region, size and sector Compare tool Two stocks side by side Fama-French 3-Factor Model Calculator Run the Fama-French 3-factor model in seconds: expected return from the market, size and value factors - free, with formula, betas and an example. Peter Lynch Fair Value Formula & Calculator Apply Peter Lynch's fair value formula in seconds: fair P/E ≈ earnings growth (+ dividend) - free, with formula and example.

Frequently asked questions

Is Intermedical Care and Lab Hospital Public Company Limited (IMH) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of 3.91 THB versus a price of 3.72 THB, about +5% (fairly valued).
What is the fair value of IMH?
Our model-based fair value for Intermedical Care and Lab Hospital Public Company Limited is 3.91 THB (as of Aug 13, 2026), built from audited fundamentals. The current price: 3.72 THB.
What is the quality score of IMH?
Intermedical Care and Lab Hospital Public Company Limited has a Quality Score of 30/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Intermedical Care and Lab Hospital Public Company Limited (IMH)?
Intermedical Care and Lab Hospital Public Company Limited reported trailing-twelve-month revenue of about 764M THB (latest available figure, as of Aug 13, 2026).
What is the net profit margin of IMH?
The net profit margin of Intermedical Care and Lab Hospital Public Company Limited is about -24.7%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

Free · no account needed

Watch Intermedical Care and Lab Hospital Public Company Limited in the live analysis

One click puts Intermedical Care and Lab Hospital Public Company Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.